Appendices

Return to: Asia Pacific Conference on National Medicines Policies

Organising committee

Professor Andrew McLachlan, University of Sydney, Australia (Chair)
Dr Henk Bekedam, Western Pacific Regional Office, World Health Organization, Philippines
Dr Jonathan Dartnell, NPS MedicineWise, Australia
Associate Professor David Newby, University of Newcastle, Australia
Dr Jane Robertson, University of Newcastle, Australia
Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines
Emeritus Professor Tony Smith, University of Newcastle, Australia
Representatives from the Australian Government Department of Health and Ageing
Lidia Dalton, Expert Events, Australia

Scientific program committee

Dr Jane Robertson, University of Newcastle, Australia (Chair)
Emeritus Professor Lloyd Sansom, University of South Australia (Co-Chair), Former Chair of Pharmaceutical Benefits Advisory Committee, Australia
Dr Henk Bekedam, Western Pacific Regional Office, World Health Organization, Philippines
Dr Jonathan Dartnell, NPS MedicineWise, Australia
Professor Ric Day, University of New South Wales, Australia
Dr Ken Harvey, La Trobe University, Australia
Dr Kathleen Holloway, South East Asia Regional Office, World Health Organization, India
Dr Richard Laing, World Health Organization, Switzerland
Dr Mary Murray, International consultant on national medicines policies, and ReAct – Action on Antibiotic Resistance
Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines
Emeritus Professor Tony Smith, University of Newcastle, Australia
Dr Krisantha Weerasuriya, World Health Organization, Switzerland

International reference panel

Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines (Chair)
Emeritus Professor Tony Smith, University of Newcastle, Australia (Co-Chair)
Dr Palitha Abeykoon, World Health Organization, Sri Lanka
Professor Kumud Kafle, TU Teaching Hospital, Kathmandu, Nepal
Professor Kazuko Kimura, Kanazawa University, Japan
Professor Soonman Kwon, Seoul National University, South Korea
Dr Hélène Moller, UNICEF, Denmark
Dr Dennis Ross-Degnan, Harvard University, USA
Dr Amit Sengupta, People’s Health Movement, India
Dr Lucky Slamet, National Agency of Drug and Food Control, Indonesia
Dr Beverley Snell, Burnet Institute, Australia
Dr Göran Tomson, Karolinska Institute, Sweden
Dr Anita Wagner, Harvard Medical School, and Yong Loo Lin School of Medicine, Singapore
Dr Brenda Waning, UNITAID, Switzerland
Dr Peter Zinck, United Nations Population Fund, Fiji

Pharmaceutical industry reference panel

Professor Ric Day (Chair), University of New South Wales, Australia
Dr Alex Condoleon, Sanofi Australia and New Zealand
Mr Will Delaat, Australia, Former Chair of Medicines Australia, Former Chief Executive Officer of Merck Sharp and Dohme Australia
Dr David Grainger, Eli Lilly, Australia
Dr Eugene Salole, Pfizer Australia
Dr Brendan Shaw, Medicines Australia
Dr Edmund Tsuei, Asia Pacific Medicine Development Consulting, Australia

Return to: Asia Pacific Conference on National Medicines Policies

Return to: Asia Pacific Conference on National Medicines Policies

Access to Medicine Index

The Access to Medicine Index provides a method to monitor and evaluate the performance of the pharmaceutical industry by assessing the output and outcomes of access-to-medicine initiatives. Some of the indicators in this index may be relevant for longitudinal or trend analysis.

The Index includes a range of measures and indicators that assess industry commitment, transparency, performance and innovation (the four strategic pillars) in relation to:

• general access to medicines management
• public policy and market influence
• research and development
• equitable pricing, manufacturing and distribution
• patents and licensing
• capability advancement in product development and distribution
• product donations and philanthropic activities.

Medicines and Insurance Coverage (MedIC) initiative

The Medicines and Insurance Coverage (MedIC) initiative aims to improve the health of populations by supporting the design, implementation, evaluation, and routine monitoring of evidence-based medicines coverage policies for vulnerable populations across the world. MedIC's goal is to improve the health and economic well-being of people in low and middle income countries by improving availability, affordability, and appropriate use of medicines through health insurance schemes.

WHO Resources

The WHO has a vast library of resources available which can be accessed in a variety of ways. Access the WHO Bookshop and WHO Library database from the Publications tab.

Institutional Repository for Information Sharing (IRIS)

Medicines Publications and Documentation
This site allows searching by title, topic, author, region or country. The public sub-collection tab links to a collection of articles on all aspects of national medicines policies. You can also create your own sub-collection of articles of interest.

Essential Medicines and Health Products Department
This page, with multiple links, identifies the range of work activities undertaken. The medicines topics tab links to an alphabetical index of topics.

Guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
This package consists of four online publications: the WHO guidelines on treating persisting pain in children and three brochures with highlights from the guidelines selected for:

• physicians and nurses
• pharmacists
• policy-makers and medicines regulatory authorities, hospital managers and health insurance managers.

Western Pacific Regional Office

South East Asian Regional Office

International Narcotics Control Board

The International Narcotics Control Board is the independent and quasi-judicial monitoring body for the implementation of the United Nations international drug control conventions. It was established in 1968 in accordance with the Single Convention on Narcotic Drugs, 1961. It had predecessors under the former drug control treaties as far back as the time of the League of Nations. The functions of the Board are laid down in the following treaties:

• the Single Convention on Narcotic Drugs, 1961
• the Convention on Psychotropic Substances of 1971
• the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.

In the discharge of its responsibilities, the Board:

• administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic substances and monitors licit activities involving drugs through a statistical returns system, with a view to assisting governments in achieving, inter alia, a balance between supply and demand
• monitors and promotes measures taken by governments to prevent the diversion of substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine whether there is a need for changes in the scope of control of Tables I and II of the 1988 Convention
• analyses information provided by governments, United Nations bodies, specialised agencies or other competent international organisations, with a view to ensuring that the provisions of the international drug control treaties are adequately carried out by governments, and recommends remedial measures
• maintains a permanent dialogue with governments to assist them in complying with their obligations under the international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance to be provided.

Regional journals

Southern Medical Review
The Southern Medical Review is published twice a year. It is an open access peer reviewed journal focusing on Pharmaceutical Policy Research. The journal provides a platform for the dissemination of commentary and empirical research findings with a view to improving rational use of and access to essential medicines.

In June 2013, this journal was re-launched as the Journal of Pharmaceutical Policy and Practice (JoPPP), as part of BioMedCentral and is an open access publication. It is relevant to research and practice in low and middle income countries.

The WHO South East Asia Journal of Public Health (WHO SEAJPH)
This is a peer-reviewed, indexed, open access quarterly publication of the World Health Organization Regional Office for South East Asia. The Journal aims to provide an avenue to scientists for publication of original research work so as to facilitate use of research for public health action.

Australian Prescriber
Australian Prescriber is Australia's national independent journal of drugs and therapeutics. Its purpose is to help health professionals make informed choices when prescribing, including whether to prescribe a drug or not. Australian Prescriber provides independent, reliable and accessible information about drugs and therapeutics. As well as publishing short didactic reviews, it facilitates debate about complex, controversial or uncertain therapeutic areas.

Return to: Asia Pacific Conference on National Medicines Policies